表紙
市場調查報告書
商品編碼
1037123

動物用參照實驗室市場:全球產業趨勢,佔有率,規模,成長,機會,預測(2021年∼2026年)

Veterinary Reference Laboratory Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

出版日期: | 出版商: IMARC Services Private Limited | 英文 145 Pages | 商品交期: 2-3個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

全球動物用參照實驗室的市場規模,2015年∼2020年以約6%的年複合成長率擴大。

人獸共通感染疾病和跨國動物的疾病(TAD)全球增加,是促進市場成長的重要要素之一。再加上寵物的飼養數大幅度增加,對寵物的偏好高漲,也推動市場成長。由於冠狀病毒感染疾病(COVID-19)全球持續擴大,在動物用參照實驗室,動物的病毒與其他病原體的影響分析的PCR檢驗的需求大幅度增加。再加上創新的迅速檢驗法和POC檢驗用的可攜式設備的開發等,各種技術的進步也成為促進成長的要素。全球動物用參照實驗室市場,預計今後5年將顯示緩慢的成長。

本報告提供全球動物用參照實驗室市場相關調查,市場概要,以及各技術,各用途,各動物類型,各地區的趨勢,及加入此市場的主要企業的簡介等資訊。

目錄

第1章 序文

第2章 範圍與調查手法

第3章 摘要整理

第4章 簡介

第5章 全球動物用參照實驗室市場

  • 市場概要
  • 市場成果
  • COVID-19的影響

第6章 市場明細,各技術

  • 臨床化學
  • 血液學
  • 免疫診斷
    • 主要的種類
  • 分子診斷
    • 主要的種類
  • 其他

第7章 市場明細,各用途

  • 臨床病理學
  • 毒物學
  • 多產性實驗
  • 其他

第8章 市場明細,各動物類型

  • 家畜
  • 寵物

第9章 市場明細,各地區

  • 北美
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 南美
    • 巴西
    • 墨西哥
    • 其他
  • 中東、非洲
    • 各國市場明細

第10章 SWOT分析

第11章 價值鏈分析

第12章 波特的五力分析

第13章 價格分析

第14章 競爭情形

  • 市場結構
  • 主要企業
  • 主要企業的簡介
    • Boehringer Ingelheim GmbH
    • IDEXX Laboratories Inc.
    • Neogen Corporation
    • Phoenix Central Laboratory for Veterinarians Inc.(Zoetis Inc.)
    • ProtaTek International Inc(Pharmgate LLC)
    • Royal GD
    • Texas A&M Veterinary Medical Diagnostic Laboratory
    • VCA Inc.(Mars Incorporated)
    • Virbac Animal Health India Private Limited
目錄
Product Code: SR1020G143_Report

The global veterinary reference laboratory market grew at a CAGR of around 6% during 2015-2020. A veterinary reference laboratory is a private commercial facility used for diagnosing zoonotic diseases in companion and livestock animals. The labs are used for conducting routine and specialty testing on animals for the identification of brucellosis, tuberculosis, anthrax, yellow fever, rabies, measles and other disorders. They are also used for running wellness screenings, pre-anesthetic evaluations and monitoring the efficacy of the therapies. Regular testing aids in animal health protection and prevents the spread of serious zoonotic diseases. They also provide technical and scientific assistance using immunodiagnostics, hematology and molecular diagnostics and are widely used for clinical pathology, bacteriology, toxicology, virology and pregnancy testing.

The increasing prevalence of zoonotic and transboundary animal diseases (TADs) across the globe is one of the key factors driving the growth of the market. Moreover, significant rise in pet ownership and increasing preference for companion animals is also driving the market growth. As the coronavirus disease (COVID-19) continues to spread across the globe, there has been a significant increase in the demand for PCR testing in veterinary reference laboratories to analyze the effect of the virus and other pathogens in animals. Additionally, various technological advancements, such as the development of innovative rapid tests and portable instruments for point-of-care (POC) testing, are acting as other growth-inducing factors. The technologies aid in the timely diagnosis, identification and management of poison sources in animals. Other factors, including increasing animal healthcare expenditures of the consumers, along with extensive research and development (R&D) activities in the field of veterinary sciences, are anticipated to drive the market further. Looking forward, IMARC Group expects the global veterinary reference laboratory market to exhibit moderate growth during the next five years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global veterinary reference laboratory market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, technology, application and animal type.

Breakup by Technology:

  • Clinical Chemistry
  • Hematology
  • Immunodiagnostics
  • ELISA
  • Lateral Flow Rapid Tests
  • Others
  • Molecular Diagnostics
  • PCR
  • Microassays
  • Others
  • Others

Breakup by Application:

  • Clinical Pathology
  • Toxicology
  • Productivity Testing
  • Others

Breakup by Animal Type:

  • Livestock Animals
  • Companion Animals

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being Boehringer Ingelheim GmbH, IDEXX Laboratories Inc., Neogen Corporation, Phoenix Central Laboratory for Veterinarians Inc. (Zoetis Inc.), ProtaTek International Inc. (Pharmgate LLC), Royal GD, Texas A&M Veterinary Medical Diagnostic Laboratory, VCA Inc. (Mars Incorporated) and Virbac Animal Health India Private Limited.

Key Questions Answered in This Report:

  • How has the global veterinary reference laboratory market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global veterinary reference laboratory market?
  • What are the key regional markets?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What is the breakup of the market based on the animal type?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global veterinary reference laboratory market and who are the key players?
  • What is the degree of competition in the industry?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Veterinary Reference Laboratory Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Clinical Chemistry
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Hematology
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Immunodiagnostics
    • 6.3.1 Market Trends
    • 6.3.2 Major Types
      • 6.3.2.1 ELISA
      • 6.3.2.2 Lateral Flow Rapid Tests
      • 6.3.2.3 Others
    • 6.3.3 Market Forecast
  • 6.4 Molecular Diagnostics
    • 6.4.1 Market Trends
    • 6.4.2 Major Types
      • 6.4.2.1 PCR
      • 6.4.2.2 Microassays
      • 6.4.2.3 Others
    • 6.4.3 Market Forecast
  • 6.5 Others
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast

7 Market Breakup by Application

  • 7.1 Clinical Pathology
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Toxicology
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Productivity Testing
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Others
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast

8 Market Breakup by Animal Type

  • 8.1 Livestock Animals
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Companion Animals
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 Boehringer Ingelheim GmbH
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
      • 14.3.1.3 Financials
    • 14.3.2 IDEXX Laboratories Inc.
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
      • 14.3.2.3 Financials
      • 14.3.2.4 SWOT Analysis
    • 14.3.3 Neogen Corporation
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Phoenix Central Laboratory for Veterinarians Inc. (Zoetis Inc.)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
    • 14.3.5 ProtaTek International Inc (Pharmgate LLC)
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
    • 14.3.6 Royal GD
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
    • 14.3.7 Texas A&M Veterinary Medical Diagnostic Laboratory
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
    • 14.3.8 VCA Inc. (Mars Incorporated)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
    • 14.3.9 Virbac Animal Health India Private Limited
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio